| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/2010 | WO2010042644A2 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 04/15/2010 | WO2010042640A1 Use of anti-il-20 antibody for treating stroke |
| 04/15/2010 | WO2010042634A1 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
| 04/15/2010 | WO2010042562A2 Muc1* antibodies |
| 04/15/2010 | WO2010042481A1 Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 04/15/2010 | WO2010042433A1 Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases |
| 04/15/2010 | WO2010042333A1 Generation of mitotic phase reporter for in vivo bioluminescence imaging in living animals |
| 04/15/2010 | WO2010042206A1 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 04/15/2010 | WO2010042201A1 Methods for treatment of focal segmental glomerulosclerosis |
| 04/15/2010 | WO2010041938A2 New virulence factors of streptococcus pneumoniae |
| 04/15/2010 | WO2010041143A2 Oral vaccines for producing mucosal immunity |
| 04/15/2010 | WO2010041140A2 Treatment of proliferative disorders with a death receptor agonist |
| 04/15/2010 | WO2010041097A1 New vaccine adjuvants |
| 04/15/2010 | WO2010041096A1 Orally administrable immunostimulant product for aquaculture |
| 04/15/2010 | WO2010041056A1 Composition comprising sortase anchored surface proteins of streptococcus uberis |
| 04/15/2010 | WO2010040882A1 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 04/15/2010 | WO2010040847A2 Recombinant protein bodies as immunogen-specific adjuvants |
| 04/15/2010 | WO2010040766A1 Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1) |
| 04/15/2010 | WO2010040710A1 Vaccine composition for use against influenza |
| 04/15/2010 | WO2010040508A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | WO2010040281A1 Humanized antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/15/2010 | WO2010040277A1 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 04/15/2010 | WO2010040271A1 Phase-transition polymeric microneedles |
| 04/15/2010 | WO2010040232A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 04/15/2010 | WO2010040209A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | WO2010040204A1 Detection of granulosa-cell tumors |
| 04/15/2010 | WO2010040173A1 A method of delivering functional agents across the blood-brain barrier |
| 04/15/2010 | WO2010023498A8 Methods of enhancing adjuvanticity of vaccine compositions |
| 04/15/2010 | WO2010014888A3 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 04/15/2010 | WO2010014784A9 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 04/15/2010 | WO2009135118A9 Lyme disease vaccine |
| 04/15/2010 | WO2009118660A4 Adam-15 antibodies and immunogenic peptides |
| 04/15/2010 | WO2009080299A8 Sm-protein based secretion engineering |
| 04/15/2010 | WO2009032913A8 Thermal inactivation of rotavirus |
| 04/15/2010 | US20100095391 Regulation of lipid droplet formation by modulation of fit1 and fit2 and uses thereof |
| 04/15/2010 | US20100093979 Fc Polypeptides With Novel Fc Ligand Binding Sites |
| 04/15/2010 | US20100093829 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 04/15/2010 | US20100093605 Peptides, derivatives and analogs thereof, and methods of using same |
| 04/15/2010 | US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 04/15/2010 | US20100093002 Diagnosis and treatment of malignant neoplasms |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092567 Immunostimulatory nanoparticles and related compositions, methods and systems |
| 04/15/2010 | US20100092566 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/15/2010 | US20100092559 Boldine compounds for promoting bone growth |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092535 Nanoporous Drug Delivery System |
| 04/15/2010 | US20100092524 Modification of exosomal components for use as a vaccine |
| 04/15/2010 | US20100092523 Molecules and methods for treatment and detection of cancer |
| 04/15/2010 | US20100092522 Immunogenic wt-1 peptides and methods of use thereof |
| 04/15/2010 | US20100092521 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 04/15/2010 | US20100092520 Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use |
| 04/15/2010 | US20100092519 Compositions comprising polysaccharide conjugates and their use as vaccines |
| 04/15/2010 | US20100092518 Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use |
| 04/15/2010 | US20100092517 Dose and localization of botulinum toxins in skin and muscle |
| 04/15/2010 | US20100092516 Bacterial ghost (bg) production process using betapropiolactone (bpl) for final inactivation |
| 04/15/2010 | US20100092515 Herpes simplex viruses and methods of viral replication |
| 04/15/2010 | US20100092514 Method and device for producing vaccine |
| 04/15/2010 | US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing |
| 04/15/2010 | US20100092512 Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection |
| 04/15/2010 | US20100092511 Escherichia coli mutants and methods of use thereof |
| 04/15/2010 | US20100092510 Turkey herpesvirus vectored recombinant containing avian influenza genes |
| 04/15/2010 | US20100092509 Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides |
| 04/15/2010 | US20100092508 Molecular Antigen Arrays |
| 04/15/2010 | US20100092505 Method for Shielding Functional Sites or Epitopes on Proteins |
| 04/15/2010 | US20100092504 Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |
| 04/15/2010 | US20100092503 Hcv fusion polypeptideds |
| 04/15/2010 | US20100092502 Modified hiv env polypeptides |
| 04/15/2010 | US20100092501 Foxp3 peptide vaccine |
| 04/15/2010 | US20100092500 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 04/15/2010 | US20100092499 Alpha Thymosin Peptides as Cancer Vaccine Adjuvants |
| 04/15/2010 | US20100092498 Anti-Tumour Vaccine Derived from Normal Chemically Modified Cells |
| 04/15/2010 | US20100092497 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 04/15/2010 | US20100092495 Potent cell-binding agent drug conjugates |
| 04/15/2010 | US20100092494 Composition and method for facilitating the internalization of a therapeutic agent into a cell |
| 04/15/2010 | US20100092493 Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation |
| 04/15/2010 | US20100092492 Vascular endothelial cell growth factor antagonists |
| 04/15/2010 | US20100092491 Anti-epcam antibody and uses thereof |
| 04/15/2010 | US20100092490 Method for assay on the effect of vascularization inhibitor |
| 04/15/2010 | US20100092489 Combination treatment of cd38-expressing tumors |
| 04/15/2010 | US20100092488 Method for Treatment or Prevention of Disease Associated Wtih Functional Disorder of Regulatory T Cell |
| 04/15/2010 | US20100092487 Toxic detection method |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092485 Genetic Markers for Predicting Responsiveness to Combination Therapy |
| 04/15/2010 | US20100092484 Cd44 antibodies |
| 04/15/2010 | US20100092483 Compositions monovalent for CD40L binding and methods of use |
| 04/15/2010 | US20100092482 Compositions monovalent for CD40L binding and methods of use |
| 04/15/2010 | US20100092481 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/15/2010 | US20100092480 Modulators of protein phosphatase 2a |
| 04/15/2010 | US20100092479 Compositions and methods for treatment of viral diseases |
| 04/15/2010 | US20100092478 Materials and methods for evaluating and treating neuromyelitis optica (nmo) |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092476 Pancreatic cancer biomarkers |
| 04/15/2010 | US20100092475 Treatment method using egfr antibodies and src inhibitors and related formulations |
| 04/15/2010 | US20100092474 Pharmaceutical combinations |
| 04/15/2010 | US20100092473 Anti-phospho-akt antibodies |
| 04/15/2010 | US20100092472 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 04/15/2010 | US20100092471 Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease |
| 04/15/2010 | US20100092470 Antibodies, analogs and uses thereof |
| 04/15/2010 | US20100092469 Antagonists of a non-selective cation channel in neural cells |
| 04/15/2010 | US20100092468 Method for predicting therapeutic responsiveness to tnf-alpha blocking agents |